Levin Easterly Partners’ Latest Portfolio: Top 5 Stock Picks

4. Pfizer Inc. (NYSE:PFE)

Levin Easterly Partners’ Stake Value: $25,641,000

Percentage of Levin Easterly Partners’ 13F Portfolio: 2.28%

Number of Hedge Fund Holders(Q1): 79

Having more than doubled its stake in pharmaceutical giant Pfizer Inc. (NYSE:PFE) during the first quarter, Levin Easterly Partners proceeded to cut its stake in the company by 25% to 489,047 shares during the second quarter. Cathie Wood’s ARK Investment Management also lowered its stake in Pfizer Inc. (NYSE:PFE) marginally by 4% to 734,165 shares during that time. Pfizer Inc. (NYSE:PFE) currently trades at a low forward price-to-earnings multiple of only 7.45 and recently made it to Insider Monkey’s list of 5 Undervalued Blue Chip Stocks to Buy Now.

On August 12, the company revealed that its 20-valent pneumococcal conjugate vaccine candidate called 20vPnC had met the co-primary endpoints in a Phase 3 trial performed on children. Pfizer Inc. (NYSE:PFE) already produces a Prevnar 13 vaccine that protects against 13 serotypes that lead to invasive pneumococcal disease. The 20vPnC promises protection against 7 new serotypes.